foxo4-dri senolytic peptide mouse model 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI Peptide - 10 mg
FOXO4 DRI Peptide 10 mg Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI Peptide Potential Interactions with Aged Cell Cultures
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




